React4life
React4life is an innovative Italian biotech company founded in 2016, specializing in the development of advanced organ-on-chip technology called MIVO®. The company's mission is to create reliable, predictive in vitro models of human biology to support biomedical research, drug development, personalized medicine, and cosmetic testing, ultimately reducing the reliance on animal testing and improving the accuracy of preclinical studies.
Industries
Nr. of Employees
small (1-50)
React4life
Products
Multi-chamber fluidic organ-on-chip platform
A patented millifluidic multi-chamber device engineered to host 3D tissue constructs and enable independent fluid control, donor/receiver compartment assays, multi-device interconnection and simulation of systemic circulation for in vitro studies.
Multi-chamber fluidic organ-on-chip platform
A patented millifluidic multi-chamber device engineered to host 3D tissue constructs and enable independent fluid control, donor/receiver compartment assays, multi-device interconnection and simulation of systemic circulation for in vitro studies.
Services
Design and execution of customized in vitro assays using perfused 3D tissue models to evaluate absorption, toxicity, drug efficacy and cosmetic protection.
Hands-on workshops teaching device operation, 3D culture techniques, microfluidic setups and experimental planning for researchers adopting perfused in vitro systems.
Commercial distribution through partnerships to make perfused organ-on-chip platforms accessible to universities, CROs and companies.
Design and execution of customized in vitro assays using perfused 3D tissue models to evaluate absorption, toxicity, drug efficacy and cosmetic protection.
Hands-on workshops teaching device operation, 3D culture techniques, microfluidic setups and experimental planning for researchers adopting perfused in vitro systems.
Commercial distribution through partnerships to make perfused organ-on-chip platforms accessible to universities, CROs and companies.
Expertise Areas
- Organ-on-chip and microphysiological systems
- 3D cell culture and organoids
- In vitro ADME and permeability testing
- Oncology models and immuno-oncology assays
Key Technologies
- Millifluidic multi-chamber organ-on-chip platforms
- Perfusion bioreactors (peristaltic/syringe pump integration)
- 3D cell culture and patient-derived organoids
- Co-culture systems (tumor–immune interactions)